Stay updated on Losmapimod in COVID: Safety & Efficacy Clinical Trial
Sign up to get notified when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.

Latest updates to the Losmapimod in COVID: Safety & Efficacy Clinical Trial page
- CheckyesterdayChange DetectedThe site revision changed from v3.7.2 to v3.8.0 in the footer; the study record remains inaccessible.SummaryDifference0.2%

- Check8 days agoChange DetectedA banner announces NIH’s website transition and says agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.SummaryDifference1%

- Check15 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov page.SummaryDifference0.2%

- Check22 days agoChange DetectedThe footer’s site revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check29 days agoChange DetectedThe study record page now shows a 403 Forbidden message with a Home link, rather than trial details.SummaryDifference0.5%

- Check43 days agoChange DetectedThe page now shows a 403 Forbidden error page, with site header and footer visible, indicating access to the study record is blocked.SummaryDifference19%

Stay in the know with updates to Losmapimod in COVID: Safety & Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.